发明名称 Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
摘要 The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system. (I)
申请公布号 US9364482(B2) 申请公布日期 2016.06.14
申请号 US201414898768 申请日期 2014.06.19
申请人 Merck Sharp & Dohme Corp. 发明人 Dai Xing;Liu Hong;Palani Anandan;He Shuwen;Nargund Ravi;Xiao Dong;Zorn Nicolas;Dang Qun;McComas Casey C.;Peng Xuanjia;Li Peng;Soll Richard
分类号 A61K31/65;A61K31/519;A61K31/517;A61K31/437;A61K31/4725;A61K31/06;C07D498/04;C07D471/04;C07D405/04;C07D475/02;C07D405/14;A61K31/5365;A61K31/53;A61K45/06 主分类号 A61K31/65
代理机构 代理人 Finnegan Alysia A.;Fuentes Gloria
主权项 1. A compound having the formula: or a pharmaceutically acceptable salt thereof, wherein: X is A is fluorophenyl;B is a) hydrogen; b) Ar;c) C1-C6 alkyl-Ar;d) —CHRa—Ar; ore) cyclopropyl;Ar is a 5-6 membered monocyclic aromatic ring with 0 or 1 heteroatom ring atoms independently selected from N and S, optionally substituted with 1 or 2 substituents independently selected from C1-C6 alkoxy, halo, and cyano;D is H or NR3SO2R4;R2 is C1-C6 alkyl;R3 is C1-C6 alkyl;R4 is C1-C6 alkyl;Ra is C1-C6 hydroxyalkyl, or alkylalkoxy;Rc is hydrogen, C1-C6 alkyl, alkylalkoxy, or —CH2NHC(O)CH3;Rd is hydrogen, F, Cl or C1-C6 alkyl;Re and Rf are independently hydrogen or C1-C6 alkyl; andRg is hydrogen or C1-C6 alkoxy.
地址 Rahway NJ US